News
Abbott Laboratories (NYSE:ABT) is a healthcare company that discovers, develops, manufactures, and sells a range of ...
Oppenheimer upgraded Microsoft's (MSFT) rating to Outperform from Perform and set a $600 price target, spotlighting the U.S. tech giant's AI opportunity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results